Altor Bioscience Raising $15 Million

Altor Bioscience Corp., a Miramar, Fla.-based drug company focused on cancer, autoimmune diseases and viral infections, is raising $15 million in Series C funding, according to VentureWire. The company previously raised around $10 million from Sanderling Ventures, Radius Ventures and TVM Capital. www.altorbioscience.com